Zinaida Good, PhD

Zinaida Good, PhD, is an instructor working at the interface between systems biology and cancer immunotherapy at Stanford University. Dr. Good’s research with Profs. Crystal L. Mackall, MD, Director of the PICI Center at Stanford Medicine, and Sylvia K. Plevritis, PhD, is focused on investigating why chimeric antigen receptor (CAR) T-cell immunotherapies succeed or fail in patients. Dr. Good earned her PhD, in Computational & Systems Immunology from Stanford University, where she trained with Profs. Garry P. Nolan, PhD, and Sean C. Bendall, PhD, and defined methods to build and leverage lymphocyte differentiation trajectories in health and cancer.

Her background is in experimental immunology and oncology and combines two years of experience working in Discovery Oncology at Genentech with BS and MS degrees in Microbiology & Immunology from the University of British Columbia, where she investigated the mechanisms of T cell memory with Prof. Michael R. Gold, MD, PhD. Her academic potential has been recognized by prestigious postdoctoral fellowships (2018 Parker Scholar, 2020 Stanford Cancer Institute Fellow), career development awards (2023 Parker Bridge Fellow, NIH K99/R00 Pathway to Independence Award), and she was named an Arthur and Sandra Irving Cancer Immunology Fellow in 2022. Dr. Good is preparing to launch an independent research program in the Department of Medicine at Stanford University with a long-term goal to understand and enhance T cell immunotherapies for cancer and autoimmune and rheumatic diseases.

• Present: Stanford University, Stanford, CA, Instructor
• 2018-2023: Stanford University, Postdoc, Systems Biology / Immunology
• 2018: Stanford University, Stanford, CA, PhD, Computational & Systems Immunology
• 2012: UBC, Vancouver, BC, Canada, MS, Microbiology & Immunology
• 2008: UBC, Vancouver, BC, Canada, BS, Microbiology & Immunology